EP2293795
Lyfjasamsetning
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
4.6.2009EP published:
12.8.2015EP application number:
09757599.7
EP translation filed:
3.11.2015Grant published:
15.11.2015EPO information:
European Patent Register
Max expiry date:
3.6.2029Expiry date:
3.6.2021
Title:
Pharmaceutical combination
Timeline
Today
4.6.2009EP application
12.8.2015EP Publication
3.11.2015Translation submitted
15.11.2015Registration published
3.6.2021Expires
Owner
Name:
Boehringer Ingelheim International GmbHAddress:
Binger Strasse 173, 55216, Ingelheim am Rhein, DE
Inventor
Name:
STEFANIC, Martin FriedrichAddress:
Ingelheim Am Rhein, DE
Name:
HILBERG, FrankAddress:
Ingelheim Am Rhein, DE
Name:
KAISER, RolfAddress:
Ingelheim Am Rhein, DE
Name:
SHAPIRO, DavidAddress:
WallingfordConnecticut, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
08157749Date:
6.6.2008Country:
EP
Number:
78882 PDate:
8.7.2008Country:
US
Classification
Categories:
A61K 9/48, A61K 31/496, A61K 31/519, A61P 35/00, A61P 3/10, A61P 17/06, A61P 19/02, A61P 25/02, A61P 9/00, A61P 11/06, A61P 27/02, A61P 1/16, A61P 43/00
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 19.5.2016
Expires: 3.6.2017
Payer: G. H. Sigurgeirsson
Number: 9
Paid: 19.5.2017
Expires: 3.6.2018
Payer: G. H. Sigurgeirsson
Number: 10
Paid: 18.5.2018
Expires: 3.6.2019
Payer: G. H. Sigurgeirsson
Number: 11
Paid: 21.5.2019
Expires: 3.6.2020
Payer: G. H. Sigurgeirsson
Number: 12
Paid: 14.4.2020
Expires: 3.6.2021
Payer: G.H. Sigurgeirsson ehf.